Condition-Specific Health
Gildeuretinol Enters Phase 3 Trial for Stargardt Disease
The deuterium-stabilized vitamin A analog moves into global pivotal testing, raising questions about regulatory classif…
All 622 stories
Condition-Specific Health
Neridronate Enters Phase 3 Trial for Rare Pain Condition CRPS-1
With an estimated 65,000 new U.S. cases annually, CRPS-1 represents a significant unmet need that could open upstream i…
Ingredients & Formulation
Koi Peptides Expands Research Catalog With HPLC-Verified Reference Compounds
The expansion targets analytical and preclinical research settings — not finished formulations or consumer supplementat…
Condition-Specific Health
Telitacicept Wins China NMPA Nod for Sjögren's Disease
The NMPA approval marks the first regulatory green light globally for a Sjögren's Disease-specific indication, spotligh…
Condition-Specific Health
Telitacicept Wins China NMPA Nod for IgA Nephropathy
The conditional approval marks a regulatory milestone for dual cytokine inhibition in a kidney disease with limited the…
Health & Wellness
Enovis DonJoy Spinamic Hybrid Brace Targets Scoliosis Compliance
The device falls outside functional foods and nutraceuticals; operators and editors should note this release is not ali…
Functional Foods & Beverages
Just Salad Expands to Altamonte Springs with Plant-Centric Menu
The fast-casual chain's Florida push signals growing operator appetite for functional, plant-centric foodservice format…
Regulatory & Policy
InspireMD Enrolls First Patient in SwitchGuard TCAR Pivotal Study
The TCAR-focused trial evaluates the SwitchGuard NPS paired with the CGuard Prime 80 cm carotid stent platform for stro…
Condition-Specific Health
Deutetrabenazine Data Show Long-Term TD Symptom Gains
New findings from Psych Congress Elevate underscore neurological symptom management advances, a space adjacent to emerg…
Ingredients & Formulation
Intravacc Advances Biologics Development With Integrated Analytics Platform
As biologics complexity grows, contract development organizations are investing in end-to-end analytical infrastructure…
Ingredients & Formulation
Optimi Health Secures Ibogaine Supply for Finished Drug Development
A recent executive order places ibogaine among prioritized psychedelic compounds, signaling a potential regulatory path…
Science & Research
Clinical Trial Summit 2026 to Address Site-Driven Enrollment Gaps
As nutraceutical brands increasingly rely on clinical substantiation to defend structure-function claims, site performa…